Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiotepa and Fludarabine Conditioning for Allo-HSCT in Lymphoid Malignancies
NCT02507479Phase 2Unknown
- Sponsor
- Sheba Medical Center
- Start
- Sep 2015
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thiotepa in multiple myeloma (MM), non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), chronic lymphocytic leukemia (CLL), sponsored by Sheba Medical Center. Status: unknown.
02
Drugs
thiotepa
03
Conditions
multiple myeloma (MM)non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT02507479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02507479.